Uganda's health ministry. It sponsored the 2026 Act that is to turn the National Drug Authority into a wider regulator, runs HPV and hepatitis B vaccination through its immunisation programme, and may give policy directions to the Uganda Cancer Institute, which gives technical guidance to the secretariat coordinating the national cancer plan for 2025/26 to 2029/30.
The Ministry of Health is responsible for Uganda's public health services. Its minister sponsored the National Drug and Health Products Authority Bill, 2025, which Parliament passed on 26 March 2026 and the President assented to on 29 April 2026. The Act repeals the 1993 law under which the National Drug Authority worked, from a commencement date the Minister appoints by statutory instrument; OnCo did not find that instrument. Its immunisation programme (UNEPI) introduced the HPV vaccine nationwide in 2015 and the hepatitis B birth dose in 2022, according to the introduction records Uganda reports to WHO. The coordinates on this record are an approximate Kampala city point.
The Uganda Cancer Institute, made an autonomous body corporate by the Uganda Cancer Institute Act 2016, may be given written policy directions by the Minister, which must not interfere with its independence. Slides on the Uganda National Cancer Control Plan 2025/26 to 2029/30, presented through the International Cancer Control Partnership in 2026, place oversight with a national steering committee under the Office of the Prime Minister and coordination with a national cancer control secretariat given technical guidance by the Uganda Cancer Institute under the Ministry, with district health committees and cancer control focal persons overseeing activities in the districts.
Uganda has no national health insurance. A National Health Insurance Bill was passed by Parliament in 2021 but not assented to; in November 2026 the Daily Monitor reported that the government planned to roll out a scheme by 2027.
For Uganda's screening programme, making sure women who test positive are treated is a better use of money than screening more women without that follow-through.
Uganda's radiotherapy has grown fast from a single centre, which the authors offer as a model for the more than 25 African countries without radiotherapy.
Brachytherapy capacity, not only external beam machines, decides whether women with cervical cancer in Uganda finish treatment in time.
Shares Kampala Cancer Registry, Uganda Cancer Institute, Cervical cancer, Breast cancer (all types).
Shares Kampala Cancer Registry, Cervical cancer, Breast cancer (all types), Prostate cancer.
Shares Kampala Cancer Registry, Cervical cancer, Breast cancer (all types), Prostate cancer.
Shares Gulu Cancer Registry, Cervical cancer, Prostate cancer.
Shares International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, Cervical cancer, Breast cancer (all types).
Shares Kampala Cancer Registry, Cervical cancer, Prostate cancer.
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, HPV & HBV vaccination.
Shares International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/